Literature DB >> 15446578

Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor.

Anne Schänzer1, Frank-Peter Wachs, Daniel Wilhelm, Till Acker, Christiana Cooper-Kuhn, Heike Beck, Jürgen Winkler, Ludwig Aigner, Karl H Plate, H Georg Kuhn.   

Abstract

Hypoxia as well as global and focal ischemia are strong activators of neurogenesis in the adult mammalian central nervous system. Here we show that the hypoxia-inducible vascular endothelial growth factor (VEGF) and its receptor VEGFR-2/Flk-1 are expressed in clonally-derived adult rat neural stem cells in vitro. VEGF stimulated the expansion of neural stem cells whereas blockade of VEGFR-2/Flk-1-kinase activity reduced neural stem cell expansion. VEGF was also infused into the lateral ventricle to study changes in neurogenesis in the ventricle wall, olfactory bulb and hippocampus. Using a low dose (2.4 ng/d) to avoid endothelial proliferation and changes in vascular permeability, VEGF stimulated adult neurogenesis in vivo. After VEGF infusion, we observed reduced apoptosis but unaltered proliferation suggesting a survival promoting effect of VEGF in neural progenitor cells. Strong expression of VEGFR-2/Flk-1 was detected in the ventricle wall adjacent to the choroid plexus, a site of significant VEGF production, which suggests a paracrine function of endogenous VEGF on neural stem cells in vivo. We propose that VEGF acts as a trophic factor for neural stem cells in vitro and for sustained neurogenesis in the adult nervous system. These findings may have implications for the pathogenesis and therapy of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15446578     DOI: 10.1111/j.1750-3639.2004.tb00060.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  125 in total

Review 1.  Epigenetics, hippocampal neurogenesis, and neuropsychiatric disorders: unraveling the genome to understand the mind.

Authors:  Jenny Hsieh; Amelia J Eisch
Journal:  Neurobiol Dis       Date:  2010-01-28       Impact factor: 5.996

2.  Characterization of neural stem/progenitor cells expressing VEGF and its receptors in the subventricular zone of newborn piglet brain.

Authors:  Jahan Ara; Saskia Fekete; Anli Zhu; Melissa Frank
Journal:  Neurochem Res       Date:  2010-06-15       Impact factor: 3.996

Review 3.  Cell-based therapy for stroke.

Authors:  Yu Luo
Journal:  J Neural Transm (Vienna)       Date:  2010-10-14       Impact factor: 3.575

Review 4.  Neurogenesis in the Adult Hippocampus.

Authors:  Gerd Kempermann; Hongjun Song; Fred H Gage
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-09-01       Impact factor: 10.005

5.  Adult neurogenesis and neurodegenerative diseases: A systems biology perspective.

Authors:  Emrin Horgusluoglu; Kelly Nudelman; Kwangsik Nho; Andrew J Saykin
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-02-16       Impact factor: 3.568

6.  Immune system modulates the function of adult neural stem cells.

Authors:  Oscar Gonzalez-Perez; Fernando Jauregui-Huerta; Alma Yadira Galvez-Contreras
Journal:  Curr Immunol Rev       Date:  2010-08-01

Review 7.  Roles for VEGF in the adult.

Authors:  Arindel S R Maharaj; Patricia A D'Amore
Journal:  Microvasc Res       Date:  2007-04-06       Impact factor: 3.514

Review 8.  Physical activity and the regulation of neurogenesis in the adult and aging brain.

Authors:  Klaus Fabel; Gerd Kempermann
Journal:  Neuromolecular Med       Date:  2008-02-20       Impact factor: 3.843

Review 9.  Gene and protein therapies utilizing VEGF for ALS.

Authors:  Orion P Keifer; Deirdre M O'Connor; Nicholas M Boulis
Journal:  Pharmacol Ther       Date:  2013-10-29       Impact factor: 12.310

10.  The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus.

Authors:  Smita Thakker-Varia; Jennifer Jernstedt Krol; Jacob Nettleton; Parizad M Bilimoria; Debra A Bangasser; Tracey J Shors; Ira B Black; Janet Alder
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.